X-153743257-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2
The NM_000033.4(ABCD1):c.1902C>T(p.Ala634Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00016 in 1,207,028 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 73 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000033.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABCD1 | NM_000033.4 | c.1902C>T | p.Ala634Ala | synonymous_variant | 9/10 | ENST00000218104.6 | NP_000024.2 | |
ABCD1 | XM_047441916.1 | c.2202C>T | p.Ala734Ala | synonymous_variant | 10/11 | XP_047297872.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCD1 | ENST00000218104.6 | c.1902C>T | p.Ala634Ala | synonymous_variant | 9/10 | 1 | NM_000033.4 | ENSP00000218104.3 | ||
PLXNB3-AS1 | ENST00000434284.1 | n.72-4679G>A | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000213 AC: 24AN: 112625Hom.: 0 Cov.: 23 AF XY: 0.000173 AC XY: 6AN XY: 34779
GnomAD3 exomes AF: 0.000406 AC: 71AN: 174817Hom.: 0 AF XY: 0.000262 AC XY: 16AN XY: 61117
GnomAD4 exome AF: 0.000154 AC: 169AN: 1094351Hom.: 0 Cov.: 32 AF XY: 0.000186 AC XY: 67AN XY: 361001
GnomAD4 genome AF: 0.000213 AC: 24AN: 112677Hom.: 0 Cov.: 23 AF XY: 0.000172 AC XY: 6AN XY: 34841
ClinVar
Submissions by phenotype
Adrenoleukodystrophy Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 27, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Nov 07, 2021 | - - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2017 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 08, 2017 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at